DARPA funds $73M program to develop shelf-stable dried blood products
DARPA has launched a $73 million initiative to create long-lasting, dried versions of plasma, platelets, and red blood cells for battlefield use. The program aims to have these dried blood products ready for field deployment by 2029, though researchers still face open questions about the safety and effectiveness of synthetic blood alternatives.